Sanchez L A, Veith F J, Ohki T, Suggs W D, Bakal C, Cynamon J, Rosenblitt G, Lyon R T
Division of Vascular Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY 10467, USA.
Ann Vasc Surg. 1999 Mar;13(2):151-7. doi: 10.1007/s100169900233.
The aim of this study was to evaluate our early experience with the Corvita endoluminal graft for the treatment of a variety of arterial injuries. Ten patients with arterial pseudoaneurysms (8) or arteriovenous fistulas (2) due to arterial injuries were followed prospectively after undergoing treatment with the endovascular graft. Our results showed that the Corvita low-profile endoluminal graft can be successfully used to treat arterial injuries but that it sometimes requires the placement of additional stents in patients with tortuous or tapering vessels. These grafts are extremely useful for the safe treatment of difficult and high-risk patients. Further improvements in available endovascular grafts and good long-term results will be necessary before considering these grafts the best treatment available for most patients with significant arterial injuries.
本研究的目的是评估我们使用Corvita腔内移植物治疗各种动脉损伤的早期经验。10例因动脉损伤导致动脉假性动脉瘤（8例）或动静脉瘘（2例）的患者在接受血管内移植物治疗后进行了前瞻性随访。我们的结果表明，Corvita低轮廓腔内移植物可成功用于治疗动脉损伤，但对于血管迂曲或逐渐变细的患者，有时需要放置额外的支架。这些移植物对于安全治疗困难和高危患者极为有用。在认为这些移植物是大多数有严重动脉损伤患者的最佳可用治疗方法之前，有必要进一步改进现有的血管内移植物并取得良好的长期效果。
